Financial overview

Nanologica financial report data and keyfigures. History for income statement, balance sheet and cash flow.

Pre
Pre
Pre

Description

Nanologica AB is engaged in the production and sales of silica-based chromatography products. The company develops and manufactures nanoporous silica particles for life science applications. The company's drug delivery platforms are NLAB Spiro, NLAB Silica, and others, which focus on producing medicines for the benefit of patients. Its geographical segments are China, India, the United States, and the Rest of the world.

Biotechnology